AUM$416.2M
Expense Ratio0.40%
NAV$59.42
Holdings—
InceptionNov 6, 2014
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
—Dividend Yield
—Expense Ratio
0.40%AUM
$416.2MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 88.50% |
| United Kingdom | 2.26% |
| Netherlands | 2.13% |
| France | 1.39% |
| Ireland | 1.34% |
| Denmark | 1.25% |
| Switzerland | 1.18% |
| Germany | 0.79% |
| Canada | 0.60% |
| Singapore | 0.17% |
| Luxembourg | 0.10% |
| Spain | 0.08% |
| China | 0.06% |
| Australia | 0.06% |
| Israel | 0.04% |
| Belgium | 0.04% |
| Taiwan | 0.01% |
| Other | 0.00% |
Fund Information
- Issuer
- Invesco
- Category
- Healthcare
- Inception Date
- Nov 6, 2014
- Description
- The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.
Similar ETFs
The Invesco NASDAQ Biotech UCITS ETF (SBIO.L) is an exchange-traded fund issued by Invesco that launched on Nov 6, 2014. It currently manages $416.2M in assets under management. The fund charges an expense ratio of 0.40%. It falls under the Healthcare category.
Top 10 holdings represent 47.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | GILD | GILEAD SCIENCES ORD | 9.65% | 0 | $0 |
| 2 | VRTX | VERTEX PHARMACEUTICALS ORD | 9.45% | 0 | $0 |
| 3 | AMGN | AMGEN ORD | 9.09% | 0 | $0 |
| 4 | REGN | REGENERON PHARMACEUTICALS ORD | 6.12% | 0 | $0 |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS ORD | 3.24% | 0 | $0 |
| 6 | INSM | INSMED ORD | 2.27% | 0 | $0 |
| 7 | BIIB | BIOGEN ORD | 2.14% | 0 | $0 |
| 8 | UTHR | UNITED THERAPEUTICS ORD | 1.79% | 0 | $0 |
| 9 | MRNA | MODERNA ORD | 1.67% | 0 | $0 |
| 10 | ARGX | ARGENX ADR REP ORD | 1.62% | 0 | $0 |
| 11 | — | ROIVANT SCIENCES ORD | 1.57% | 0 | $0 |
| 12 | RPRX | ROYALTY PHARMA CL A ORD | 1.53% | 0 | $0 |
| 13 | RVMD | REVOLUTION MEDICINES ORD | 1.47% | 0 | $0 |
| 14 | INCY | INCYTE ORD | 1.42% | 0 | $0 |
| 15 | ILMN | ILLUMINA ORD | 1.42% | 0 | $0 |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
—
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | SBIO.L | Healthcare(223 ETFs) |
|---|---|---|
| Fund Info | ||
| Expense Ratio | 0.40% | 0.60% |
| AUM | $416.2M | $1.24B |
| Dividend Yield | — | 2.75% |
| Avg Volume | — | 800.9K |
| Holdings | — | 171 |
| Performance | ||
| 1-Month Return | — | -4.57% |
| 6-Month Return | — | +4.90% |
| YTD Return | — | -1.70% |
| 1-Year Return | — | +15.18% |
Compare with Another ETF
Search for an ETF to compare with SBIO.L: